Filtered By:
Cancer: Skin Cancer

This page shows you your search results in order of date.

Order by Relevance | Date

Total 17 results found since Jan 2013.

How Could Digital Technology Make An Impact On Primary Care?
I truly hope that very soon I do not have to make an appointment at the GP when I suspect signs of a disease, but my GP will send me a message that she spotted something irregular in my latest test results and my digital health data, so I’d better visit. Let me show you in detail how primary care should be carried out in the future! Digital health should become an organic part of primary care in the future I live a fairly healthy life. I use data to improve my lifestyle and to make better decisions by optimising my sleep pattern, my physical, my cognitive or my emotional abilities; and I had several genetic tests....
Source: The Medical Futurist - September 21, 2023 Category: Information Technology Authors: berci.mesko Tags: Digital Health Research Healthcare Innovation technology wearables GP primary care general practitioner Source Type: blogs

5 Scenarios Of How Your Health Data Can Be (Or Was Already) Stolen
I really don’t want to sound like Aunt Karen, suspecting a culprit hiding behind every bush, but chances are your health data was or will be stolen. This is a strong statement and might sound paranoid. But, as the old joke goes: being paranoid doesn’t mean someone is not after you.  Here we will introduce five general scenarios of how unknown third-party actors can access your health data without your knowledge (and consent). We introduce these to paint a clearer picture of how medical data can change hands and help you prepare to avoid it – as much as possible. You had a genetic test done You o...
Source: The Medical Futurist - September 15, 2022 Category: Information Technology Authors: Andrea Koncz Tags: TMF Forecast Artificial Intelligence in Medicine Digital Health Research Future of Food Healthcare Policy Security & Privacy Source Type: blogs

Cardiac tumours
Cardiac tumours are most often secondaries from malignancies of breast, lung or malignant melanoma. Primary tumours of the heart are most often benign, of which about half are myxomas. Malignant primary tumours of the heart contribute to about a quarter of the primary cardiac tumours. The commonest primary malignant tumour of the heart would be a sarcoma [1]. Cardiac tumours may present with cardiovascular or constitutional symptoms. Sometimes they are incidentally detected on echocardiography or other imaging modalities. Left atrial myxoma on echocardiogram Computed tomography and magnetic resonance imaging can give addi...
Source: Cardiophile MD - August 25, 2022 Category: Cardiology Authors: Johnson Francis Tags: General Cardiology Source Type: blogs

What Has A.I. In Medicine Ever Done For Us? At Least 50 Things!
Remember Monty Python’s brilliant Life of Brian movie scene where the Judean Jewish insurgent commando, planning the abduction of Pilate’s wife in return for all the horrors they had to endure from the Roman Empire, asks the rhetorical question: what have the Romans ever done for us? With the hype and overmarketing, not to speak about the fears around A.I, we asked the same question. What has A.I. in medicine ever done for us? Well, we found at least 50 things. I have 50 responses to the pressing question on everyone’s mind who is interested in healthcare but tired of the hype or the doomsday scenarios around A.I....
Source: The Medical Futurist - March 1, 2022 Category: Information Technology Authors: berci.mesko Tags: Artificial Intelligence in Medicine Future of Medicine AI cancer diagnostics digital health Healthcare Innovation medical Radiology technology medical imaging treatment administration digital health technology Source Type: blogs

Big Pharma, Big Money: Johnson & Johnson, Pfizer, Bayer, Novartis in digital health
In a recent series of articles, we explored the latest moves of Tech Giants like Amazon, NVIDIA and Microsoft in the field of digital health. Analysing these recent developments can give us a better idea regarding where they are focusing the efforts, and how it might shape the future path of healthcare.  But equally, if not more, strong players in this field are pharmaceutical giants, as their resources and influence can significantly shape or alter the course of this path. As such, we are kickstarting a new series of articles focusing on the digital health efforts of 14 global pharma companies. While those heavywe...
Source: The Medical Futurist - October 12, 2021 Category: Information Technology Authors: Pranavsingh Dhunnoo Tags: Future of Medicine Future of Pharma digital health novartis pfizer J&J big pharma Johnson&Johnson Bayer Source Type: blogs

What Has A.I. In Medicine Ever Done For Us? At Least 45 Things!
Remember Monty Python’s brilliant Life of Brian movie scene where the Palestinian insurgent commando, planning the abduction of Pilate’s wife in return for all the horrors they had to endure from the Roman Empire, asks the rhetorical question: what have the Romans ever done for us? With the hype and overmarketing, not to speak about the fears around A.I, we asked the same question. What has A.I. in medicine ever done for us? Well, we found at least 45 things. I have 45 responses to the pressing question on everyone’s mind who is interested in healthcare but tired of the hype or the doomsday scenarios around A.I.: ...
Source: The Medical Futurist - May 28, 2019 Category: Information Technology Authors: nora Tags: Artificial Intelligence in Medicine Future of Medicine administration AI cancer diagnostics digital health digital health technology Healthcare Innovation medical medical imaging Radiology treatment Source Type: blogs

Top Smart Algorithms In Healthcare
As artificial intelligence tools have been invading more or less every area of healthcare, we made a list to keep track of the top smart algorithms aiming for better diagnostics, more sophisticated patient care or further sighted predictions of diseases. Does A.I. beat doctors? Only if you lived under a rock for the last couple of years, could you not have heard about artificial intelligence. Some might have even come across the spread and potential of A.I. in healthcare. Not only smart algorithms themselves but also the hype around A.I. has grown immensely, thus every time a new study about deep learning or machine...
Source: The Medical Futurist - February 5, 2019 Category: Information Technology Authors: nora Tags: Artificial Intelligence in Medicine AI cancer death future Health Healthcare pathology prediction Radiology technology Source Type: blogs

We live in an epidemic of health misinformation. Can mobile apps help?
An app to diagnose melanoma, it sounds convenient and less expensive than going to the dermatologist. But what if you were told that the app had an error rate of 30 percent, would you still take the risk? The advent of digital media has broken physicians’ monopoly on health information, and this freedom comes at a price. Misinformation isn’t just a political issue, but a problem with serious health ramifications. Digital health is nothing new. In short, it’s “the convergence of health care and the Internet.” Today, digital health is a billion dollar industry including a direct to consumer segment made up ...
Source: Kevin, M.D. - Medical Weblog - September 23, 2017 Category: General Medicine Authors: < a href="http://www.kevinmd.com/blog/post-author/john-long-and-jingyi-liu" rel="tag" > John Long and Jingyi Liu < /a > Tags: Tech Cardiology Mobile health Primary Care Source Type: blogs

Onco-cardiology, or Cardio-oncology
I was at a Cardiology Education Meeting where a case was presented of a patient receiving a monoclonal antibody for melanoma, who may have then developed myocarditis.Onco-cardiology (or cardio-oncology) is the study of the cardiac effects of cancer treatment but also used to refer to patients who are cancer survivors with a cardiac condition or people living with both conditions.Though not a new term, I don ' t remember coming across it before.  Here is some introductory reading:Some recent freely available articles (with links to PubMed):Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatme...
Source: Browsing - July 3, 2017 Category: Databases & Libraries Tags: cancer cardiology Source Type: blogs

Praluent, the Next Expensive "Game Changer," Blockbuster," "New Hope," - But Not Yet Shown to Benefit Patients
ConclusionsThe NEJM study was accompanied by an editorial by Stone and Lloyd-Jones(2) which documented that drugs previously shown to lower cholesterol were never proved to do any good for patients, and concluded,it would be premature to endorse these drugs for widespread use before the ongoing randomized trials, appropriately powered for primary end-point analysis and safety assessment, are available. After an FDA advisory committee recommended approval of aliromucab and another PCSK9 inhibitor in June, 2015, John Mandrola entitled a Medscape article,Dear FDA: Resist the Urge on PCSK9 DrugsHis reasons included lack o...
Source: Health Care Renewal - August 5, 2015 Category: Health Management Tags: aliromucab evidence-based medicine health care prices manipulating clinical research PCSK9 inhibitor Praluent Regeneron Sanofi-Aventis Source Type: blogs

How Manipulated Clinical Evidence Could Distort Guidelines - the Case of Statins for Primary Prevention
This study excluded many patient for whom the statins were not contraindicated or warned against: uncontrolled hypertension; type 1 or type 2 diabetes mellitus on insulin or with a HgBA1C at least 10%; and body weight more than 50% "desirable limit for height."  (Based on the official contraindications and warnings for commonly used statins, e.g., see contraindications for Lipitor here, active liver disease, pregnancy for likely to become pregnant, nursing mothers, hypersensitivity to the medicine; and warnings: use of cyclosprine or strong CYP3A4 inhibitors, uncontrolled hypothyroidism, renal impairment.)  Thus ...
Source: Health Care Renewal - December 3, 2013 Category: Health Medicine and Bioethics Commentators Tags: American College of Cardiology American Heart Association clinical trials conflicts of interest evidence-based medicine guidelines manipulating clinical research review articles Source Type: blogs

Christie Gets a Band
I had blogged a while ago about New Jersey governor Chris Christie's angry response to a former White House physician's opinion that he needed to think about losing some weight.  Christie basically told the doc she needed to mind her own business.  My take was that, morbid obesity being a risk factor for coronary artery disease, stroke, and early death, Christie's weight would be a issue I considered if and when he decided to run for the Presidency in 2016.  In order to be reassured that he could withstand the stress and pressure of being the leader of the world's only superpower, I ...
Source: Buckeye Surgeon - May 9, 2013 Category: Surgeons Authors: Jeffrey Parks MD Source Type: blogs

Transcript of Dr. Bihari Video
00:00 to 02.26—Dr. Bihari gives his background and credentials. Dr. Bihari: My medical training started at Harvard Medical School. I graduated in 1957. Then I trained in Internal Medicine at one of the Harvard teaching hospitals in Boston, Beth Israel, and then in Neurology at Massachusetts General in Boston. Then I went to the National Institutes of Health for two years doing brain physiology—brain research. I did another residency training in Psychiatry in New York, at Columbia Presbyterian Medical Center and then, over the following five or six years, I got very involved in working in Drug Addiction. By 1974, I was...
Source: HONEST MEDICINE: My Dream for the Future - May 16, 2011 Category: Consumer Health News Authors: JuliaS1573 at aol.com (Julia Schopick) Tags: Anecdotal Treatments HONEST MEDICINE Integrative Medicine Low Dose Naltrexone Obituaries Source Type: blogs